Analyst Ratings January 29, 2026

DA Davidson Nudges Up Western Alliance Target to $105, Keeps Buy Rating

Analyst cites modest quarterly beats, supportive 2026 guidance and efforts to trim NPAs amid cash flow concerns

By Nina Shah WAL
DA Davidson Nudges Up Western Alliance Target to $105, Keeps Buy Rating
WAL

DA Davidson increased its price objective for Western Alliance Bancorporation to $105 from $104 and left its Buy rating intact. The move follows a quarter that modestly outperformed pretax estimates and more strongly beat on an after-tax basis due to a lower quarterly tax rate. The bank’s recent guidance and revenue momentum underpin the analyst's outlook, even as cash-flow metrics and deposit-cost risks attract attention from other firms.

Key Points

  • DA Davidson raised its price target on Western Alliance to $105 from $104 and maintained a Buy rating, implying about 19% upside from the $88.67 share price.
  • The bank modestly beat pretax estimates for the quarter and more substantially beat on an after-tax basis due to a lower tax rate; trailing-12-month diluted EPS was $8.73, giving a P/E of 10.25.
  • InvestingPro shows 10% revenue growth over the last twelve months and analysts expect roughly 15% growth for fiscal 2026; management’s focus on reducing NPAs and initial 2026 guidance are cited as supportive for above-consensus EPS.

DA Davidson raised its price objective on Western Alliance Bancorporation to $105.00 from $104.00 on Thursday, while keeping a Buy rating on the shares. The revised target implies roughly a 19% upside from the current share price of $88.67 and sits above the broader analyst consensus, which reflects a roughly 14% potential upside.


DA Davidson's adjustment follows Western Alliance's most recent quarterly report, which the firm said modestly beat pretax estimates. The outperformance was larger on an after-tax basis, attributable to a lower effective tax rate in the quarter. On a trailing-12-month basis the bank reported diluted earnings per share of $8.73, translating to a price-to-earnings multiple of 10.25 at the current share price.

The research note indicated that Western Alliance's initial guidance for 2026 supports DA Davidson's above-consensus earnings-per-share forecast. The firm highlighted strong top-line revenue growth as a driver of year-over-year operating leverage that should help underpin profitability.

Data from InvestingPro cited by the analyst shows the bank generated 10% revenue growth over the last twelve months, and consensus estimates among analysts point to roughly 15% revenue growth for fiscal 2026. InvestingPro analysis also noted that the stock is trading at a relatively low P/E ratio compared with its near-term earnings growth potential.


DA Davidson drew attention to management’s focus on reducing non-performing assets during the first half of the year, a development the firm believes would be positively received by investors. The research note pointed to the potential for lower NPA levels to alleviate some market concerns around asset-quality risk.

At the same time, the bank faces cash-flow challenges. InvestingPro figures referenced by DA Davidson show a negative free cash flow yield of -35%, indicating the company is currently consuming cash quickly. The firm’s move to raise the price target to $105 from $104 represents a modest upward revision and signals continued confidence in Western Alliance's financial trajectory despite that cash flow dynamic.


InvestingPro's Fair Value assessment, as noted by the analyst, indicates that the stock is currently fairly valued. For investors seeking a deeper dive, the platform offers a Pro Research Report on the company, which is part of a coverage universe exceeding 1,400 U.S. equities.

Additional corporate results cited in the note show Western Alliance delivered robust fourth-quarter 2025 results, beating both earnings and revenue expectations. The company reported fourth-quarter EPS of $2.59, above an anticipated $2.39, representing an 8.37% surprise. Revenue for the quarter was $980.9 million versus an expected $913.4 million, a 7.39% upside to consensus.

In a separate analyst development, JPMorgan moved its rating on Western Alliance from Overweight to Neutral while lifting its price target to $105.00 from $100.00. JPMorgan's change reflected concerns around potential headwinds from Earnings Credit Rate deposit costs, even as the firm expects Western Alliance to be a strong EPS and tangible book value grower by 2026.


Overall, the DA Davidson update reiterates a constructive view on Western Alliance’s near-term earnings prospects and growth trajectory, anchored by recent revenue momentum and management’s stated priorities for reducing NPAs. Counterbalancing factors flagged by other analysts and InvestingPro data include high cash burn as shown by negative free cash flow yield and potential deposit-cost risks tied to Earnings Credit Rates.

This coverage note reflects current analyst assessments and company disclosures referenced above and does not add information beyond those points.

Risks

  • Negative free cash flow yield of -35% indicates the company is consuming cash quickly, creating cash-flow risk for the bank and potentially affecting funding and liquidity considerations in the financial sector.
  • Potential deposit-cost pressures tied to Earnings Credit Rate deposit costs, a concern highlighted by JPMorgan, could weigh on margins and earnings trends for the bank and similar regional lenders.
  • Non-performing asset levels remain a focus; until NPAs are demonstrably reduced, asset-quality concerns could persist in the regional banking sector and influence investor sentiment.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026